Growth Metrics

Biocryst Pharmaceuticals (BCRX) Retained Earnings: 2010-2015

Historic Retained Earnings for Biocryst Pharmaceuticals (BCRX) over the last 3 years, with Sep 2015 value amounting to -$492.8 million.

  • Biocryst Pharmaceuticals' Retained Earnings fell 8.01% to -$492.8 million in Q3 2015 from the same period last year, while for Sep 2015 it was -$492.8 million, marking a year-over-year decrease of 8.01%. This contributed to the annual value of -$467.9 million for FY2014, which is 10.69% down from last year.
  • As of Q3 2015, Biocryst Pharmaceuticals' Retained Earnings stood at -$492.8 million, which was down 3.06% from -$478.2 million recorded in Q2 2015.
  • In the past 5 years, Biocryst Pharmaceuticals' Retained Earnings ranged from a high of -$325.9 million in Q2 2011 and a low of -$492.8 million during Q3 2015.
  • Over the past 3 years, Biocryst Pharmaceuticals' median Retained Earnings value was -$456.2 million (recorded in 2014), while the average stood at -$455.4 million.
  • Data for Biocryst Pharmaceuticals' Retained Earnings shows a maximum YoY dropped of 19.20% (in 2011) over the last 5 years.
  • Biocryst Pharmaceuticals' Retained Earnings (Quarterly) stood at -$353.5 million in 2011, then dropped by 11.05% to -$392.6 million in 2012, then dropped by 7.67% to -$422.7 million in 2013, then declined by 10.69% to -$467.9 million in 2014, then declined by 8.01% to -$492.8 million in 2015.
  • Its Retained Earnings stands at -$492.8 million for Q3 2015, versus -$478.2 million for Q2 2015 and -$483.1 million for Q1 2015.